awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37672654-1C80404D-BBA6-4B2C-B4B9-71F2B81D3DC7
Q37672654-1C80404D-BBA6-4B2C-B4B9-71F2B81D3DC7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37672654-1C80404D-BBA6-4B2C-B4B9-71F2B81D3DC7
Controlling escape from angiogenesis inhibitors.
P2860
Q37672654-1C80404D-BBA6-4B2C-B4B9-71F2B81D3DC7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37672654-1C80404D-BBA6-4B2C-B4B9-71F2B81D3DC7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5401b9ee949582aa48ded53ccb75644cc8c29309
P2860
Potent preclinical impact of metronomic low-dose oral topotecan combined with the antiangiogenic drug pazopanib for the treatment of ovarian cancer.